Rolph Timothy

CIK 00017794791 companySOUTH SAN FRANCISCO, CA

SEC Profile

Transactions

Companies

Filings

CIK

0001779479

Recent Transactions

50 trades

Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−49,945→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−3,421→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−26,152→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−5,032→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−389→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−84,051→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−29,074→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−56,579→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−2,328→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−238,339→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-12-09−119,969→ 0 total
Disposition to Issuer
Akero Therapeutics, Inc.
Common Stock
2025-12-09−43,810→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-11-25$28.35/sh+3,527→ 132,998 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-11-25−2,796→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-11-25$21.10/sh+4,739→ 282,149 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-11-25−3,527→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-11-25$21.09/sh+4,284→ 180,346 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-11-25$0.61/sh+94,268→ 277,410 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-11-25−4,284→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-11-25−4,739→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-11-25−43,064→ 0 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-11-25$0.61/sh+2,796→ 183,142 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-11-25$6.36/sh+43,064→ 176,062 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-11-25−94,268→ 0 total
Gift
Akero Therapeutics, Inc.
Common Stock
2025-11-17−37,100→ 129,471 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-10-07−12,500→ 49,945 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-10-07$28.35/sh+12,500→ 179,071 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-10-07$46.82/sh−1,037→ 166,571 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-10-07$46.01/sh−11,463→ 167,608 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-09-11$43.02/sh−553→ 166,571 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-09-08$21.09/sh+7,044→ 174,168 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-09-08$6.36/sh+5,161→ 179,329 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-09-08$44.17/sh−12,466→ 167,158 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-09-08−295→ 62,445 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-09-08$28.35/sh+295→ 179,624 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-09-08$44.88/sh−34→ 167,124 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-09-08−7,044→ 389 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-09-08−5,161→ 0 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-08-05$49.49/sh−6,962→ 167,124 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-08-05$21.09/sh+12,500→ 179,624 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-08-05$49.06/sh−5,538→ 174,086 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-08-05−12,500→ 7,433 total
Exercise/Conversion
Akero Therapeutics, Inc.
Common Stock
2025-07-07$21.09/sh+12,500→ 179,624 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-07-07$50.93/sh−10,634→ 168,990 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-07-07$52.62/sh−41→ 167,124 total
Exercise/Conversion
Akero Therapeutics, Inc.
Stock Option (Right to Buy)
2025-07-07−12,500→ 19,933 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-07-07$52.00/sh−1,825→ 167,165 total
Award
Akero Therapeutics, Inc.
Common Stock
2025-06-30$23.87/sh+890→ 167,124 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-18$54.84/sh−1,129→ 166,234 total
Sale
Akero Therapeutics, Inc.
Common Stock
2025-06-10$54.00/sh−2,358→ 167,363 total

Companies

Akero Therapeutics, Inc.
Chief Scientific Officer

Recent Filings

Address

601 GATEWAY BOULEVARD SUITE 350

SOUTH SAN FRANCISCO, CA, 94080

View on SEC.gov